Form 4: BridgeBio Pharma CEO Sells Shares
Insider Transaction (Form 4)
Neil Kumar, Chief Executive Officer and a Director of BridgeBio Pharma, Inc., sold 44,980 shares of common stock on August 18, 2026.
Summary
- Open-market sale: disposed of 1,900 Common Stock at $81.15 ($154,184) on August 18, 2026; holds 276,407 after (Direct).
- Open-market sale: disposed of 17,279 Common Stock at $82.21 ($1,420,514) on August 18, 2026; holds 259,128 after (Direct).
- Open-market sale: disposed of 14,602 Common Stock at $82.99 ($1,211,852) on August 18, 2026; holds 244,526 after (Direct).
- Open-market sale: disposed of 1,199 Common Stock at $83.77 ($100,444) on August 18, 2026; holds 243,327 after (Direct).
- Open-market sale: disposed of 8,100 Common Stock at $83.86 ($679,256) on August 19, 2026; holds 507,586 after (Indirect).
- Open-market sale: disposed of 1,800 Common Stock at $84.69 ($152,436) on August 19, 2026; holds 505,786 after (Indirect).
- Open-market sale: disposed of 100 Common Stock at $85.65 ($8,565) on August 19, 2026; holds 505,686 after (Indirect).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative but low-conviction signal: an insider sold $3,727,251 of stock under a pre-arranged Rule 10b5-1 plan, which is typically routine.
Insider Transactions
Neil Kumar — Director, Officer (Chief Executive Officer)
Transaction made under a Rule 10b5-1 trading plan.
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-08-18 | Open-market sale | Common Stock | 1,900 | $81 | $154.2K | 276,407 |
| 2026-08-18 | Open-market sale | Common Stock | 17,279 | $82 | $1.4M | 259,128 |
| 2026-08-18 | Open-market sale | Common Stock | 14,602 | $83 | $1.2M | 244,526 |
| 2026-08-18 | Open-market sale | Common Stock | 1,199 | $84 | $100.4K | 243,327 |
| 2026-08-19 | Open-market sale | Common Stock | 8,100 | $84 | $679.3K | 507,586 |
| 2026-08-19 | Open-market sale | Common Stock | 1,800 | $85 | $152.4K | 505,786 |
| 2026-08-19 | Open-market sale | Common Stock | 100 | $86 | $8.6K | 505,686 |
Key Dates
| Date | Description |
|---|---|
| 2026-08-18 | Open-market sale (1,900 shares) |
| 2026-08-18 | Open-market sale (17,279 shares) |
| 2026-08-18 | Open-market sale (14,602 shares) |
| 2026-08-18 | Open-market sale (1,199 shares) |
| 2026-08-19 | Open-market sale (8,100 shares) |
| 2026-08-19 | Open-market sale (1,800 shares) |
| 2026-08-19 | Open-market sale (100 shares) |
Keywords
insider transaction, Form 4, BBIO, BridgeBio Pharma, Inc., bearish, Neil Kumar
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.